The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma - With special reference to the serum levels of des-gamma-carboxy prothrombin

被引:173
作者
Shirabe, Ken
Itoh, Shinji
Yoshizumi, Tomoharu
Soejima, Yuji
Taketomi, Akinobu
Aishima, Shin-Ichi
Maehara, Yoshihiko
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Pathol Anat, Fukuoka 8128582, Japan
关键词
hepatocellular carcinoma; des-gamma-carboxy prothrombin; microvascular incvasion; liver transplantation;
D O I
10.1002/jso.20655
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The microvascular invasion of cancer cells (mvi) is a good prognostic factor after orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC). The aim of this study is to predict mvi in patients with HCC who were candidates for OLT. We studied 218 patients with HCC resections who had HCC without any extrahepatic metastases and vascular invasion detected during preoperative evaluation. We analyzed the clinico-pathological data of these patients to predict the mvi presence. The mvi prediction scoring system was made and the accuracy of this system was examined using independent clinico-pathologic factors. The size and histological grade of the tumor were significantly correlated with the mvi. The des-gamma-carboxy prothrombin (DCP) is a mvi predictor. The sensitivity of our mvi prediction system was 75% and the specificity was 85% in 32 patients who underwent living-donor liver transplantations for HCC. Our study shows that besides the tumor size and histological grade, a measurement of the serum DCP levels could be a good predictor for mvi. A tumor biopsy and a preoperative measurement of DCP could improve the selection of patients with HCC for OLT. Our scoring system for mvi provides us a precise prediction of the presence of mvi.
引用
收藏
页码:235 / 240
页数:6
相关论文
共 31 条
[1]
Adachi E, 1996, CANCER, V77, P2022, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO
[2]
2-S
[3]
RISK-FACTORS FOR INTRAHEPATIC RECURRENCE IN HUMAN SMALL HEPATOCELLULAR-CARCINOMA [J].
ADACHI, E ;
MAEDA, T ;
MATSUMATA, T ;
SHIRABE, K ;
KINUKAWA, N ;
SUGIMACHI, K ;
TSUNEYOSHI, M .
GASTROENTEROLOGY, 1995, 108 (03) :768-775
[4]
Portal vein evaluation with US: Comparison to angiography combined with CT arterial portography [J].
Bach, AM ;
Hann, LE ;
Brown, KT ;
Getrajdman, GI ;
Herman, SK ;
Fong, YM ;
Blumgart, LH .
RADIOLOGY, 1996, 201 (01) :149-154
[5]
LIVER RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS [J].
BISMUTH, H ;
CHICHE, L ;
ADAM, R ;
CASTAING, D ;
DIAMOND, T ;
DENNISON, A .
ANNALS OF SURGERY, 1993, 218 (02) :145-151
[6]
Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation? [J].
Colella, G ;
DeCarlis, L ;
Rondinara, GF ;
Sansalone, CV ;
Belli, LS ;
Aseni, P ;
Slim, AI ;
Gelosa, F ;
Iamoni, GM ;
Corti, A ;
Mazza, E ;
Arcieri, K ;
Giacomoni, A ;
Minola, E ;
Ideo, G ;
Forti, D .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :492-494
[7]
DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
[8]
Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation [J].
Esnaola, NF ;
Lauwers, GY ;
Mirza, NQ ;
Nagorney, DM ;
Doherty, D ;
Ikai, I ;
Yamaoka, Y ;
Regimbeau, JM ;
Belghiti, J ;
Curley, SA ;
Ellis, LM ;
Vauthey, JN .
JOURNAL OF GASTROINTESTINAL SURGERY, 2002, 6 (02) :224-232
[9]
Tumor involvement in hepatic veins: Comparison of MR imaging and US for preoperative assessment [J].
Hann, LE ;
Schwartz, LH ;
Panicek, DM ;
Bach, AM ;
Fong, YM ;
Blumgart, LH .
RADIOLOGY, 1998, 206 (03) :651-656
[10]
Liver transplantation for hepatocellular carcinoma [J].
Hemming, AW ;
Cattral, MS ;
Reed, AI ;
Van der Werf, WJ ;
Greig, PD ;
Howard, RJ .
ANNALS OF SURGERY, 2001, 233 (05) :652-658